SCHEMBL8320094

SCHEMBL8320094

Cc1ccc(CN2C(=O)OC(C)(C)C2=O)cc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 3/20 0.73
PRTN3 P24158 2/20 0.73
CTSG P08311 1/20 0.73
MAPT P10636 3/20 0.48
NPSR1 Q6W5P4 2/20 0.48
HPGD P15428 1/20 0.48
TSHR P16473 1/20 0.48
TP53 P04637 2/20 0.43
SMN1; SMN2 Q16637 4/20 0.42
GAA P10253 1/20 0.42
GRM2 Q14416 1/20 0.42
NR3C2 P08235 1/20 0.41
KMT2A Q03164 3/20 0.40
LMNA P02545 2/20 0.40
MEN1 O00255 2/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
CRHBP P24387 1/20 0.39
CYP2C19 P33261 1/20 0.39
HTT P42858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5257643 0.83 ELANE (0.73) ELANEPRTN3CTSGMAPTNPSR1
SCHEMBL28548453 0.71 KDM4E (0.60) MAPTSMN1; SMN2GAAKMT2ALMNA
SCHEMBL1432439 0.71 GABRA1 (0.50) ELANEPRTN3CTSGNPSR1HPGD
Ethadione SCHEMBL35279 0.70 ELANE (0.55) ELANEPRTN3CTSGMAPTNPSR1
SCHEMBL4914804 0.70 ELANE (0.63) ELANEPRTN3CTSGTSHRTP53
SCHEMBL5006337 0.69 ELANE (0.54) ELANEPRTN3CTSGLMNAALDH1A1
SCHEMBL7309157 0.69 ELANE (0.53) ELANEPRTN3CTSGGRM2LMNA
SCHEMBL12704514 0.69 TP53 (0.53) MAPTTP53SMN1; SMN2GAAKMT2A
SCHEMBL4757301 0.69 ELANE (0.53) ELANEPRTN3CTSGGRM2LMNA
SCHEMBL4800190 0.69 MGLL (0.78) MAPTTP53SMN1; SMN2GAAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1592426-B1 2-CYANOPYRROLOPYRIMIDINES AND PHARMACEUTICAL USES THEREOF NOVARTIS AG (CH) 2007-12-19 EP disclosed
WO-2004069256-A1 2-CYANOPYRROLOPYRIMIDINES AND PHARMACEUTICAL USES THEREOF NOVARTIS AG (CH) 2004-08-19 WO disclosed